Log in
Enquire now
Darnitsa (pharmaceutical company)

Darnitsa (pharmaceutical company)

Darnitsa is a Ukrainian pharmaceutical corporation and one of the leading pharmaceutical producers in Ukraine.

OverviewStructured DataIssuesContributors

Contents

darnitsa.ua/en
darnitsa.ua
Is a
Organization
Organization
Company
Company
Product
Product

Company attributes

Industry
Pharmaceutical industry
Pharmaceutical industry
Location
Kyiv
Kyiv
B2X
B2B
B2B
CEO
‌
Andrii Obrizan
Number of Employees (Ranges)
501 – 1,000
Phone Number
+380445668984
Number of Employees
853
Full Address
6 Novodarnytska St.
Founded Date
January 1, 1938
Key People
‌
Dmytro Shymkiv
0
Country
Ukraine
Ukraine
Headquarters
Kyiv
Kyiv
0

Other attributes

Company Operating Status
Active
Contact Page URL
darnitsa.ua/en/contacts
Wikidata ID
Q12099571

Darnitsa is a Ukrainian pharmaceutical corporation and one of the leading pharmaceutical producers in Ukraine. The company is a leading producer of pharmaceuticals by volume in Ukraine. Company’s portfolio includes more than 250 names of medical products: vaccines, drops, powders, infusions and more.

History

The company was founded in 1930 in Kiev, Ukraine, when a branch of the Ukrainian Institute of Endocrinology was opened. Later the branch became a separate enterprise – Darnitsa Chemical-Pharmaceutical Plant.

Since 1994, The Chemical and Pharmaceutical Plant Darnitsa has been reorganized into CJSC Darnitsa Pharmaceutical Company.

In 2002 Darnitsa was one of the first Ukrainian pharmaceutical companies to implement the international quality standards GMP (Good Manufacturing Practice). In 2012, the form of ownership changed from closed to a private joint-stock company.

In September 2018 former deputy head of the Presidential Administration of Ukraine Dmytro Shymkiv chaired the board of the PrJSC "Pharmaceutical Firm "Darnitsa" managing company.

Darnitsa Pharmaceutical Company entered the Top-20 most innovative companies of Ukraine in 2016 according to Forbes Ukraine magazine. The company was repeatedly nominated for Choice of the Year and was in the top-3 of the best employers of Ukraine. In 2018, "Darnitsa" was included in the top five of the rating "The Most Expensive Brands of Ukraine" of the magazine "Korrespondent".In 2018, Darnitsa increased net profit by 31% compared to 2017 – up to 449.1 million UAH (16.7 million USD). Net income from sales of products for this period increased by 18,7% – to 3 billion UAH (111.1 million USD).In 2019 Darnitsa’s net profit increased by 30%. In comparison to 2018 net sales revenue increased by 10,3% - to USD 123,419 million. Darnitsa’s income tax in 2019 was USD 4,5 million

During the COVID-19 epidemics in Ukraine Darnitsa bought 6 lung ventilators and presented them to the Ukrainian hospitals. The company also joined to the nationwide fundraising campaign aimed to buy 50 lug ventilators. The fundraiser started on March 20 2020 on initiative of Zagoriy Foundation and Ukrainian Philanthropic Marketplace.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more companies like Darnitsa (pharmaceutical company)

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.